[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.55.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Bailey RL, Gahche JJ, Lentino CV,  et al.  Dietary supplement use in the United States, 2003-2006.  J Nutr. 2011;141(2):261-26621178089PubMedGoogle ScholarCrossref
2.
Gahche J, Bailey R, Burt V,  et al.  Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994).  NCHS Data Brief. 2011;(61):1-821592424PubMedGoogle Scholar
3.
Boffetta P, Couto E, Wichmann J,  et al.  Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).  J Natl Cancer Inst. 2010;102(8):529-53720371762PubMedGoogle ScholarCrossref
4.
Löf M, Sandin S, Lagiou P, Trichopoulos D, Adami HO, Weiderpass E. Fruit and vegetable intake and risk of cancer in the Swedish women's lifestyle and health cohort.  Cancer Causes Control. 2011;22(2):283-28921125418PubMedGoogle ScholarCrossref
5.
Hung HC, Joshipura KJ, Jiang R,  et al.  Fruit and vegetable intake and risk of major chronic disease.  J Natl Cancer Inst. 2004;96(21):1577-158415523086PubMedGoogle ScholarCrossref
6.
Li K, Kaaks R, Linseisen J, Rohrmann S. Vitamin/mineral supplementation and cancer, cardiovascular, and all-cause mortality in a German prospective cohort (EPIC-Heidelberg).  Eur J Nutr. 2012;51(4):407-41321779961PubMedGoogle ScholarCrossref
7.
Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study.  Am J Epidemiol. 2011;173(8):906-91421343248PubMedGoogle ScholarCrossref
8.
Larsson SC, Akesson A, Bergkvist L, Wolk A. Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women.  Am J Clin Nutr. 2010;91(5):1268-127220335555PubMedGoogle ScholarCrossref
9.
Neuhouser ML, Wassertheil-Smoller S, Thomson C,  et al.  Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts.  Arch Intern Med. 2009;169(3):294-30419204221PubMedGoogle ScholarCrossref
10.
Stevens VL, McCullough ML, Diver WR,  et al.  Use of multivitamins and prostate cancer mortality in a large cohort of US men.  Cancer Causes Control. 2005;16(6):643-65016049802PubMedGoogle ScholarCrossref
11.
Jacobs EJ, Connell CJ, Patel AV,  et al.  Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States).  Cancer Causes Control. 2001;12(10):927-93411808712PubMedGoogle ScholarCrossref
12.
Giovannucci E, Stampfer MJ, Colditz GA,  et al.  Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.  Ann Intern Med. 1998;129(7):517-5249758570PubMedGoogle ScholarCrossref
13.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group.  N Engl J Med. 1994;330(15):1029-10358127329PubMedGoogle ScholarCrossref
14.
Hennekens CH, Buring JE, Manson JE,  et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.  N Engl J Med. 1996;334(18):1145-11498602179PubMedGoogle ScholarCrossref
15.
Lee IM, Cook NR, Gaziano JM,  et al.  Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.  JAMA. 2005;294(1):56-6515998891PubMedGoogle ScholarCrossref
16.
Lonn E, Bosch J, Yusuf S,  et al; HOPE and HOPE-TOO Trial Investigators.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.  JAMA. 2005;293(11):1338-134715769967PubMedGoogle ScholarCrossref
17.
Lin J, Cook NR, Albert C,  et al.  Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.  J Natl Cancer Inst. 2009;101(1):14-2319116389PubMedGoogle ScholarCrossref
18.
Gaziano JM, Glynn RJ, Christen WG,  et al.  Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.  JAMA. 2009;301(1):52-6219066368PubMedGoogle ScholarCrossref
19.
US Department of Agriculture and US Department of Health and Human Services.  Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm. Accessed October 8, 2012
20.
NIH State-of-the-Science Panel.  National Institutes of Health State-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention.  Ann Intern Med. 2006;145(5):364-37116880454PubMedGoogle ScholarCrossref
21.
Ervin RB, Wright JD, Kennedy-Stephenson J. Use of dietary supplements in the United States, 1988-94.  Vital Health Stat 11. 1999;(244):i-iii, 1-1410464471PubMedGoogle Scholar
22.
Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.  Ann Epidemiol. 2000;10(2):125-13410691066PubMedGoogle ScholarCrossref
23.
Sesso HD, Buring JE, Christen WG,  et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.  JAMA. 2008;300(18):2123-213318997197PubMedGoogle ScholarCrossref
24.
Steering Committee of the Physicians' Health Study Research Group.  Final report on the aspirin component of the ongoing Physicians' Health Study.  N Engl J Med. 1989;321(3):129-1352664509PubMedGoogle ScholarCrossref
25.
Lang JM, Buring JE, Rosner B, Cook N, Hennekens CH. Estimating the effect of the run-in on the power of the Physicians' Health Study.  Stat Med. 1991;10(10):1585-15931947514PubMedGoogle ScholarCrossref
26.
Neppl-Huber C, Zappa M, Coebergh JW,  et al;  EUNICE Survival Working Group.  Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.  Ann Oncol. 2012;23(5):1325-133421965474PubMedGoogle ScholarCrossref
27.
Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr. Multivitamin use and mortality in a large prospective study.  Am J Epidemiol. 2000;152(2):149-16210909952PubMedGoogle ScholarCrossref
28.
Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma.  J Am Acad Dermatol. 2011;65(6):1145-115121664718PubMedGoogle ScholarCrossref
29.
Kwan ML, Greenlee H, Lee VS,  et al.  Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study.  Breast Cancer Res Treat. 2011;130(1):195-20521559824PubMedGoogle ScholarCrossref
30.
Chan AL, Leung HW, Wang SF. Multivitamin supplement use and risk of breast cancer: a meta-analysis.  Ann Pharmacother. 2011;45(4):476-48421487086PubMedGoogle ScholarCrossref
31.
Pocobelli G, Peters U, Kristal AR, White E. Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality.  Am J Epidemiol. 2009;170(4):472-48319596711PubMedGoogle ScholarCrossref
32.
Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.  Cancer Causes Control. 2009;20(5):691-69819093214PubMedGoogle ScholarCrossref
33.
White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer.  Cancer Epidemiol Biomarkers Prev. 1997;6(10):769-7749332757PubMedGoogle Scholar
34.
Jacobs EJ, Connell CJ, Chao A,  et al.  Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter?  Am J Epidemiol. 2003;158(7):621-62814507597PubMedGoogle ScholarCrossref
35.
Blot WJ, Li JY, Taylor PR,  et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population.  J Natl Cancer Inst. 1993;85(18):1483-14928360931PubMedGoogle ScholarCrossref
36.
Qiao YL, Dawsey SM, Kamangar F,  et al.  Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial.  J Natl Cancer Inst. 2009;101(7):507-51819318634PubMedGoogle ScholarCrossref
37.
Heart Protection Study Collaborative Group.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.  Lancet. 2002;360(9326):23-3312114037PubMedGoogle ScholarCrossref
38.
Clarke R, Halsey J, Lewington S,  et al; B-Vitamin Treatment Trialists' Collaboration.  Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.  Arch Intern Med. 2010;170(18):1622-163120937919PubMedGoogle ScholarCrossref
39.
Hercberg S, Galan P, Preziosi P,  et al.  The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.  Arch Intern Med. 2004;164(21):2335-234215557412PubMedGoogle ScholarCrossref
40.
Cauley JA, Chlebowski RT, Wactawski-Wende J,  et al.  The Women's Health Initiative (WHI) calcium plus vitamin D supplementation trial: health outcomes 5 years after trial completion [abstract].  J Bone Miner Res. 2012;27:(suppl 1)  Google Scholar
41.
Boeing H, Bechthold A, Bub A,  et al.  Critical review: vegetables and fruit in the prevention of chronic diseases.  Eur J Nutr. 2012;51(6):637-66322684631PubMedGoogle ScholarCrossref
42.
Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk.  Am J Clin Nutr. 2003;78(3):(Suppl)  559S-569S12936950PubMedGoogle Scholar
43.
Morris MC, Tangney CC. A potential design flaw of randomized trials of vitamin supplements.  JAMA. 2011;305(13):1348-134921467288PubMedGoogle ScholarCrossref
44.
Sesso HD, Gaziano JM, VanDenburgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study.  Control Clin Trials. 2002;23(6):686-70212505246PubMedGoogle ScholarCrossref
45.
Block G, Jensen CD, Norkus EP,  et al.  Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study.  Nutr J. 2007;6(1):3017958896PubMedGoogle ScholarCrossref
46.
Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ. Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes.  J Am Diet Assoc. 2007;107(8):1322-133217659898PubMedGoogle ScholarCrossref
47.
Park K, Harnack L, Jacobs DR Jr. Trends in dietary supplement use in a cohort of postmenopausal women from Iowa.  Am J Epidemiol. 2009;169(7):887-89219208725PubMedGoogle ScholarCrossref
Original Contribution
ONLINE FIRST
November 14, 2012

Multivitamins in the Prevention of Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial

Author Affiliations

Author Affiliations: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Gaziano, Sesso, Christen, Bubes, Schvartz, Manson, Glynn, and Buring and Mss Smith and MacFadyen); VA Boston Healthcare System, Boston, Massachusetts (Dr Gaziano); and Departments of Epidemiology (Drs Sesso, Manson, and Buring) and Biostatistics (Dr Glynn), Harvard School of Public Health, Boston, Massachusetts. Dr Gaziano is also Contributing Editor, JAMA.

JAMA. 2012;308(18):1871-1880. doi:10.1001/jama.2012.14641
Abstract

Context Multivitamin preparations are the most common dietary supplement, taken by at least one-third of all US adults. Observational studies have not provided evidence regarding associations of multivitamin use with total and site-specific cancer incidence or mortality.

Objective To determine whether long-term multivitamin supplementation decreases the risk of total and site-specific cancer events among men.

Design, Setting, and Participants A large-scale, randomized, double-blind, placebo-controlled trial (Physicians' Health Study II) of 14 641 male US physicians initially aged 50 years or older (mean [SD] age, 64.3 [9.2] years), including 1312 men with a history of cancer at randomization, enrolled in a common multivitamin study that began in 1997 with treatment and follow-up through June 1, 2011.

Intervention Daily multivitamin or placebo.

Main Outcome Measures Total cancer (excluding nonmelanoma skin cancer), with prostate, colorectal, and other site-specific cancers among the secondary end points.

Results During a median (interquartile range) follow-up of 11.2 (10.7-13.3) years, there were 2669 men with confirmed cancer, including 1373 cases of prostate cancer and 210 cases of colorectal cancer. Compared with placebo, men taking a daily multivitamin had a statistically significant reduction in the incidence of total cancer (multivitamin and placebo groups, 17.0 and 18.3 events, respectively, per 1000 person-years; hazard ratio [HR], 0.92; 95% CI, 0.86-0.998; P = .04). There was no significant effect of a daily multivitamin on prostate cancer (multivitamin and placebo groups, 9.1 and 9.2 events, respectively, per 1000 person-years; HR, 0.98; 95% CI, 0.88-1.09; P = .76), colorectal cancer (multivitamin and placebo groups, 1.2 and 1.4 events, respectively, per 1000 person-years; HR, 0.89; 95% CI, 0.68-1.17; P = .39), or other site-specific cancers. There was no significant difference in the risk of cancer mortality (multivitamin and placebo groups, 4.9 and 5.6 events, respectively, per 1000 person-years; HR, 0.88; 95% CI, 0.77-1.01; P = .07). Daily multivitamin use was associated with a reduction in total cancer among 1312 men with a baseline history of cancer (HR, 0.73; 95% CI, 0.56-0.96; P = .02), but this did not differ significantly from that among 13 329 men initially without cancer (HR, 0.94; 95% CI, 0.87-1.02; P = .15; P for interaction = .07).

Conclusion In this large prevention trial of male physicians, daily multivitamin supplementation modestly but significantly reduced the risk of total cancer.

Trial Registration clinicaltrials.gov Identifier: NCT00270647

×